Mutant huntingtin protein decreases with CAG repeat expansion
Author Information
Author(s): Christian Landles, Georgina F Osborne, Jemima Phillips, Maria Canibano-Pico, Iulia M Nita, Nadira Ali, Konstantin Bobkov, Jonathan R Greene, Kirupa Sathasivam, Gillian P Bates
Primary Institution: University College London
Hypothesis
How does the mutant huntingtin protein level change with increasing CAG repeat length in Huntington's disease?
Conclusion
As the CAG repeat length increases, the level of full-length mutant huntingtin protein decreases while the pathogenic HTT1a protein increases.
Supporting Evidence
- The study found that mutant HTT levels decreased to 10% of wild-type levels in mice with the longest CAG repeats.
- HTT1a protein levels increased with longer CAG repeats, indicating a shift in protein expression.
- Assays designed to detect full-length mutant HTT were not effective in accurately measuring protein levels across different CAG lengths.
Takeaway
In Huntington's disease, as the genetic mutation gets longer, the amount of a harmful protein decreases, but another harmful version of the protein increases.
Methodology
The study used mouse models to analyze the levels of mutant huntingtin protein and HTT1a protein through western blotting and various bioassays.
Potential Biases
Potential bias in assay performance based on the length of the CAG repeat.
Limitations
The assays used may not accurately reflect the changes in protein levels due to the influence of CAG repeat length on assay performance.
Participant Demographics
Mouse models with varying CAG repeat lengths (20, 50, 80, 111, 140, and 190).
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website